Category: Smartphone Device Alert Settings

1The U.S. Food and Drug Administration (FDA) is alerting patients who use diabetes devices and …

Announcement, Diabetes check, FDA warning, Global Pharma News, Smartphone Device Alert Settings February 12, 2025 JYOTI

FDA Alerts Patients to Regularly Check Diabetes-Related Smartphone Device Alert Settings, Especially Following Phone Hardware or Software Changes

Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetesMarch 5, 2025
Insulin resistance, often induced by obesity, is the underlying abnormality for type
EU Approves Xalkori for Advanced Lung and Rare Cancers in Adults and YouthMarch 3, 2025
The European Medicines Agency (EMA) has granted approval for Xalkori, a targeted
Eli Lilly unveils plans to invest $27bn in four new US manufacturing sitesFebruary 28, 2025
The investment, which Lilly claims is the largest pharmaceutical manufacturing investment in
FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage DiseaseFebruary 24, 2025
Food and Drug Administration approved Ctexli (chenodiol) for the treatment of cerebrotendinous
Sanofi and Regeneron’s Dupixent granted FDA priority review for bullous pemphigoidFebruary 22, 2025
The acceptance of the Dupixent (dupilumab; Sanofi, Regeneron) application in this indication may give
Merck’s Welireg granted EC approval for von Hippel-Lindau disease and kidney cancerFebruary 19, 2025
Up to 15,000 people in Europe are living with VHL, a rare
FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of DiabetesFebruary 15, 2025
the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin
Scientists Just Discovered Why Antibiotics Struggle To Eliminate Certain InfectionsFebruary 13, 2025
Antibiotic failure is mainly due to nutrient-starved bacteria, not persisters, making infections
Oncology Center of Excellence Guidance DocumentsFebruary 13, 2025
OCE Guidance Agenda The Oncology Center of Excellence (OCE) is sharing potential
FDA Alerts Patients to Regularly Check Diabetes-Related Smartphone Device Alert Settings, Especially Following Phone Hardware or Software ChangesFebruary 12, 2025
1The U.S. Food and Drug Administration (FDA) is alerting patients who use diabetes
Lupin and Natco Receive Approval from U.S. FDA for Bosentan Tablets for Oral SuspensionFebruary 11, 2025
That’s an exciting development! The approval for generic Bosentan Tablets for Oral
Outbreak Investigation of Salmonella: Mini PastriesFebruary 10, 2025
Do not sell or serve recalled Sweet Cream-Brand Mini Pastries. FDA’s investigation